心脏磁共振组织追踪推导的全局纵向舒张期应变率作为预测肥厚型心肌病不良结局的新标志物
本研究纳入98例肥厚型心肌病患者(44例有左心室流出道梗阻,54例无梗阻),用心脏磁共振组织追踪测量左心室全局心肌力学,随访平均4.5年。梗阻亚组左心室全局径向、周向和纵向舒张期应变率均较无梗阻亚组减低(均p<0.05)。纵向舒张期应变率低于0.33 1/s的患者无主要不良心血管事件生存率显著更低(log-rank p<0.05),多变量分析显示纵向舒张期应变率是结局的最强预测因子(HR 2.65,95%CI 2.21-11.44,p<0.05)。
要点
- 纵向舒张期应变率低于0.33 1/s的肥厚型心肌病患者主要不良心血管事件风险更高。
- 左心室流出道梗阻患者全局径向、周向和纵向舒张期应变率均较无梗阻者减低。
- 心脏磁共振组织追踪推导的纵向舒张期应变率可能有助于肥厚型心肌病风险分层。
核心结论
- 心脏磁共振组织追踪推导的全局纵向舒张期应变率可能被认为是预测肥厚型心肌病患者不良结局的新颖且易于操作的标志物,有助于风险分层,但需进一步验证性研究。
研究设计与样本
- 研究纳入98例诊断为肥厚型心肌病的患者,其中44例有左心室流出道梗阻,54例无梗阻,随访至指定终点。
- 所有参与者在研究 entry 时接受心脏磁共振组织追踪检查以评估左心室全局心肌力学。
关键影像表现/征象
- 与无梗阻亚组相比,梗阻亚组左心室全局径向、周向和纵向舒张期应变率幅度均减低(均p<0.05)。
诊断标准与关键数值
- 纵向舒张期应变率 cut-off 值为0.33 1/s;低于此值的患者在无梗阻、梗阻及总体队列中无主要不良心血管事件生存率均显著更低(log-rank p均<0.05)。
- 多变量分析中,校正基线和心脏磁共振变量后,纵向舒张期应变率仍为结局的最强预测因子(风险比2.65;95%置信区间2.21-11.44;p<0.05)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文结论指出需进一步验证性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To examine the prognostic value of global peak diastolic strain rate (PDSR) derived from cardiac magnetic resonance (CMR) tissue tracking (CMR-TT) in predicting adverse outcomes in hypertrophic cardiomyopathy (HCM) patients.
MATERIALS AND METHODS: A total of 98 patients diagnosed with HCM (44 patients had left ventricle [LV] outflow tract obstruction [LVOTO] and 54 patients did not) were enrolled and followed for the specified endpoint. LV global myocardial mechanics was assessed in all participants using CMR-TT at study entry.
RESULTS: Compared with the non-obstructive subgroup, the obstructive subgroup demonstrated deteriorated magnitude of LV global radial, circumferential, and longitudinal PDSR (all p<0.05). After a mean follow-up period of 4.5 years, 24 patients reached an endpoint before the end of the study. Furthermore, when using the specified cut-off value (0.33 1/s) of longitudinal PDSR, the Kaplan-Meier curve demonstrated that patients with lower longitudinal PDSR had a significantly lower freedom from major adverse cardiovascular events (MACE) compared with their counterparts in the non-obstructive, obstructive, and overall cohorts (all log-rank p<0.05). Multivariable analysis showed that longitudinal PDSR remained the strongest predictor of outcome after adjusting for baseline and CMR variables (hazard ratio, 2.65; 95% confidence interval, 2.21-11.44; p<0.05).
CONCLUSION: CMR-TT-derived longitudinal PDSR is probably considered a novel and easy-to-perform marker for predicting adverse outcomes in HCM patients, which is beneficial to risk stratification. Further confirmatory studies are needed.
引用
- Li ZL, He S, Xia CC, et al. Global longitudinal diastolic strain rate as a novel marker for predicting adverse outcomes in hypertrophic cardiomyopathy by cardiac magnetic resonance tissue tracking. Clin Radiol. 2020. PMID: 32948315. doi:10.1016/j.crad.2020.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。